Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:BASI

Bioanalytical Systems (BASI) Stock Price, News & Analysis

Bioanalytical Systems logo

About Bioanalytical Systems Stock (NASDAQ:BASI)

Advanced Chart

Key Stats

Today's Range
$1.66
$1.74
50-Day Range
$14.04
$22.50
52-Week Range
$3.05
$21.08
Volume
172,009 shs
Average Volume
122,925 shs
Market Capitalization
$18.81 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BASI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bioanalytical Systems and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BASI Stock News Headlines

What a Basic Metabolic Panel (BMP) Measures
NVIDIA's Worst Nightmare?
$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the REAL fortune they expect to come from quantum computing - a $2 trillion explosion by 2035. The kicker? One company is America's FIRST commercial supplier of the material that makes it possible.tc pixel
10 Analysts Assess NIO: What You Need To Know
What Is Bioprocessing? Here Are the Basics
What 11 Analyst Ratings Have To Say About Analog Devices
Demystifying Airbnb: Insights From 13 Analyst Reviews
7 Best B2B Database Providers for 2024
See More Headlines

BASI Stock Analysis - Frequently Asked Questions

Bioanalytical Systems, Inc. (NASDAQ:BASI) issued its quarterly earnings results on Monday, February, 8th. The company reported ($0.03) EPS for the quarter, topping the consensus estimate of ($0.19) by $0.16. The firm had revenue of $17.89 million for the quarter. Bioanalytical Systems had a negative net margin of 7.75% and a negative trailing twelve-month return on equity of 42.74%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Bioanalytical Systems investors own include Meta Platforms (META), Enphase Energy (ENPH), Overstock.com (OSTK), Riot Platforms (RIOT), Twilio (TWLO), Boeing (BA) and NVIDIA (NVDA).

Company Calendar

Last Earnings
2/08/2021
Today
9/02/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Commercial Physical Research
Sub-Industry
N/A
Current Symbol
NASDAQ:BASI
CIK
720154
Fax
N/A
Employees
397
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.35)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$4.68 million
Net Margins
-7.75%
Pretax Margin
N/A
Return on Equity
-42.74%
Return on Assets
-6.38%

Debt

Debt-to-Equity Ratio
2.49
Current Ratio
0.48
Quick Ratio
0.46

Sales & Book Value

Annual Sales
$60.47 million
Price / Sales
0.31
Cash Flow
$0.00 per share
Price / Cash Flow
558.40
Book Value
$0.69 per share
Price / Book
2.45

Miscellaneous

Outstanding Shares
11,131,000
Free Float
N/A
Market Cap
$18.81 million
Optionable
Not Optionable
Beta
1.92
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:BASI) was last updated on 9/2/2025 by MarketBeat.com Staff
From Our Partners